Evaxion A (EVAX) Cash from Financing Activities (2020 - 2022)
Evaxion A posted quarterly Cash from Financing Activities of -$300000.0 for Q2 2022, down 101.19% year-on-year from $25.2 million in Q2 2021, and down 103.88% on a QoQ basis from $7.7 million in Q1 2022.
Evaxion A (EVAX) has 3 years of Cash from Financing Activities data on file, last reported at -$300000.0 in Q2 2022.
- For the quarter ending Q2 2022, Cash from Financing Activities fell 101.19% year-over-year to -$300000.0; the trailing twelve-month figure through Jun 2022 stood at $57.8 million (up 1.64% YoY), and the FY2025 full-year result was $22.4 million, up 70.69% from the prior year.
- Cash from Financing Activities for Q2 2022 stood at -$300000.0, down from $7.7 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $25.3 million in Q1 2021 and bottomed at -$300000.0 in Q2 2022.
- The 3-year median for Cash from Financing Activities is $7.1 million (2020), against an average of $11.2 million.
- The widest annual swing landed in 2021, when Cash from Financing Activities jumped 140388.89%; it then slumped 101.19% in 2022.
- A 3-year view of Cash from Financing Activities shows it stood at $6.4 million in 2020, then jumped by 290.38% to $25.2 million in 2021, then plunged by 101.19% to -$300000.0 in 2022.
- The last three Cash from Financing Activities figures came in at -$300000.0 (Q2 2022), $7.7 million (Q1 2022), and $25.2 million (Q3 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 7.00 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -600,000.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 53,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -538.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -802.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 15.71 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 238.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -300,000.00 |
| Jun 30, 2022 | -300,000.00 |
| Mar 31, 2022 | 7.74 Mn |
| Mar 31, 2022 | 7.74 Mn |
| Sep 30, 2021 | 25.15 Mn |
| Sep 30, 2021 | 25.15 Mn |
| Jun 30, 2021 | 25.22 Mn |
| Jun 30, 2021 | 25.22 Mn |
| Mar 31, 2021 | 25.25 Mn |
| Mar 31, 2021 | 25.25 Mn |
| Sep 30, 2020 | 6.44 Mn |
| Sep 30, 2020 | 6.44 Mn |
| Jun 30, 2020 | -36,000.00 |
| Jun 30, 2020 | -36,000.00 |
| Mar 31, 2020 | -18,000.00 |
| Mar 31, 2020 | -18,000.00 |